About Us | Contact Us | User Login

  • Home
  • About ForeseeHome
    • Learn More About ForeseeHome
    • Monitoring Process
    • Program Information
    • ForeseeHome FAQs
    • Technology
    • Published Research
    • Clinical Trials
      • AREDS2 ForeseeHome Study
      • Wet AMD Monitoring Study
  • Threat of AMD
    • Learn More About the Threat of AMD
    • Dry AMD
    • Wet AMD
    • Importance of Early Detection
    • Inherent Flaws of the Amsler Grid
    • AMD Resources
  • Patient Stories
  • In the News
  • Find a Doctor
    • First Prescriber Sites
    • AREDS2 Study Sites
    • Wet AMD Monitoring Study Sites
CSS Drop Down Menu by PureCSSMenu.com
  • Information for Physicians
    • ForeseeHome Program Information
    • ForeseeHome Physician FAQs
    • Publications
    • Case Studies
    • Physician Testimonials
    • For Current Practices
    • Events
    • Contact Us

TEXT

Home> In the News

In the News

Notal Vision™ Supports the St. Louis VisionWalk

ST. LOUIS, MO (September 6, 2010) – Notal Vision, developers of the ForeseeHome AMD Monitoring Program are proud to sponsor the St. Louis VisionWalk.  VisionWalk is a national fundraising event of the Foundation Fighting Blindness.  Since its inception in the spring of 2006, the program has raised over $15 million to fund research aimed at saving sight. 

 

“We are pleased to support the VisionWalk St. Louis and the effort to fund research to reduce the devastating impact of sight threatening diseases” says Garret O’Connell, Notal Vision’s Vice President of Marketing and Sales.

 

The St. Louis VisionWalk will take place on Saturday, September 25, 2010 at Tower Grove Park.

 

About Notal Vision
Notal Vision was founded in 2000 by ophthalmologists and medical professionals determined to reduce vision loss associated with Age-Related Macular Degeneration (AMD).  With leading experts in the field, this team of medical professionals and scientists developed a new technology for monitoring AMD, the leading cause of significant vision loss and blindness in the western world. This new technology, Preferential Hyperacuity Perimetry, is now providing eye care professionals around the world with valuable clinical data for monitoring patients with AMD.  The Notal Vision management team consists of medical and business professionals with offices in the U.S. and Israel.

 

More AMD News Click to read more news


Nortal Vision


 

 

© Copyright 2011 Notal VisionTM | Terms & Conditions | Privacy Policy | Customer Support Center: (888) 910-2020

Like us on Facebook Subscribe to our YouTube Channel